Medical Economics February 13, 2025
Richard Payerchin

Bargaining for widely used prescription drugs may save money for Medicare, but AAR wants seniors to see better prices at the pharmacy counter.

The Alliance for Aging Research (AAR), based in Washington, D.C., has grown to become a leading patient advocacy organization. The Alliance also works with federal agencies, elected officials and partner organizations “to advance policies that support research and health aging.” Adina Lasser is director of public policy and government affairs for the Alliance. While many have praised the Medicare Drug Price Negotiation Program as a means to help beneficiaries, AAR has questioned whether the main motive is to save money for Medicare. In this video series, Lasser explains that distinction and what it means for patients.

Medicare...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Biotechnology, CMS, Conferences / Podcast, Govt Agencies, Insurance, Medicare, Pharma, Pharma / Biotech, Trends
House eyes Medicare payment boost for behavioral health services
Medicare Program Integrity and Efforts to Root Out Improper Payments, Fraud, Waste and Abuse
Navigating The Path To Medicare Dental Coverage
Medicare Drug Price Negotiation: Saving money for Medicare, but what about patients? - 2
The Imperative to Modify the Medicare “Use in the Home” Policy

Share This Article